Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer. - Wikidata - wikimedia - TriplyDB

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

http://www.wikidata.org/entity/Q37046332

about

A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.Recent Advances in Understanding Werner Syndrome.RECQ1 expression is upregulated in response to DNA damage and in a p53-dependent manner.Role of Protein Linked DNA Breaks in Cancer.Topoisomerase I and Genome Stability: The Good and the Bad.Hydroxylated-graphene quantum dots induce DNA damage and disrupt microtubule structure in human esophageal epithelial cells.New Insights Into DNA Helicases as Druggable Targets for Cancer Therapy

P2860

Q28817426-B33CCD4A-8494-45EF-A6BB-98D5A7FB9901 Q33649056-96946FE1-C1FE-40C4-91F2-3D271B19E878 Q38731624-1DB4B2BA-3BEB-4166-8DAF-FD3182C91658 Q42367242-77BCB56A-3244-47A9-A13E-7C2A7179619A Q43089122-44E77D0E-89AA-47FA-AE10-C28DBD7C455A Q46243206-B64C855A-1175-469E-98F8-B245D95A1407 Q49607733-59716B7B-9833-41FB-838E-0B0F83382105 Q52580260-CDECF4C7-E60C-4098-97C2-396A1EDA9304 Q56476152-FD665C8C-B733-4C6B-BF31-13F3C441B47B

P2860

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

http://www.wikidata.org/entity/Q37046332

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

@en

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

@nl

type

label

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

@en

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

@nl

prefLabel

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

@en

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

@nl

P1433

Q37046332-85E7F599-A4AE-4FE2-9E07-125436C8A6D9

P1476

Q37046332-09D86CAE-2CE1-4801-BCF3-D24124009763

P2093

Q37046332-0B4E54C4-E226-40F1-825F-9FE4AE3FE24F

Q37046332-1F659B51-3CC5-4BE3-AAB1-184C908B8476

Q37046332-5683AD5D-3289-45B7-8D38-FB54A501AEE2

Q37046332-6092F5D5-0E9A-4518-87C7-DB4E42D52D77

Q37046332-9BB68475-DFEE-4A83-9005-66302909A93D

Q37046332-EAAA1F92-06E1-4BA0-AD21-F88E09EECCDF

P2860

Q37046332-01D1DC16-6733-4782-BE7C-A0C26D6C3E23

Q37046332-07AA7FF1-157A-4167-B78B-6BDB7C6B7523

Q37046332-0AA60EAD-50B7-439C-A195-1F104BD0BB32

Q37046332-111C4836-F680-4B01-9A90-727640C70E95

Q37046332-16F51F40-C8B2-4DA8-B642-A731BCB13678

Q37046332-292337CB-032C-42DD-8C78-FB1C76C84A23

Q37046332-2A0AFF54-C773-4C46-BAD7-76F896360ED3

Q37046332-2A5FA501-9777-48D3-BBF6-41DE2BAF3B23

Q37046332-40F5E9E1-8492-4912-83F5-6C95B4ACE729

Q37046332-44356C75-001B-40B0-9066-C07F17FA8FE4

P304

Q37046332-D6E35267-A61B-4256-A727-99E60173B4F3

P31

Q37046332-C9924819-E858-4282-ADCA-A1803BA65B86

P356

Q37046332-AF4B5E14-B19D-43C3-9504-CCDBE62D3E9B

P407

Q37046332-141BDBB3-C46F-443E-9CA8-B5AD4394EE68

P433

Q37046332-90DC5A68-D282-415F-B2A9-A4E9898768D0

P478

Q37046332-A8CE6685-F796-4FE8-A77D-EE2FD66E9865

P50

Q37046332-05CADDE3-4C47-4514-AF89-1196D62B57F0

Q37046332-3B57B555-3125-4B54-B38A-760C59BBF4D9

Q37046332-54AE1475-95D5-4F9B-A452-CD5FE9453811

Q37046332-A1C62DBB-51A4-4E10-9E25-6FAF5317773B

Q37046332-E8985179-883D-496E-9C29-5FFA81889611

P577

Q37046332-F28E322F-B02B-44E0-A641-D909327DC9FC

P698

Q37046332-C1ED723C-8E75-4F03-AA7A-DC92B0A57BBA

P932

Q37046332-1061F7EC-7FA1-4A37-A8F7-7044F717A138

P356

ONCOTARGET.7906

P1433

P1476

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

@en

P2093

Arvind Arora

http://www.w3.org/2001/XMLSchema#string

Deborah L Croteau

http://www.w3.org/2001/XMLSchema#string

Graham Ball

http://www.w3.org/2001/XMLSchema#string

Huiming Lu

http://www.w3.org/2001/XMLSchema#string

Raghavendra A Shamanna

http://www.w3.org/2001/XMLSchema#string

Vilhelm A Bohr

http://www.w3.org/2001/XMLSchema#string

P2860

Spectrum and risk of neoplasia in Werner syndrome: a systematic review

Nucleolar localization of the Werner syndrome protein in human cells

SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage

Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer

The Werner's Syndrome RecQ helicase/exonuclease at the nexus of cancer and aging

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Modulation of camptothecin analogs in the treatment of cancer: a review.

Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges.

Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.

Acetylation of WRN protein regulates its stability by inhibiting ubiquitination.

P304

13269-13284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.7906

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Srinivasan Madhusudan

Mohammed A Aleskandarany

P577

2016-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26959889

http://www.w3.org/2001/XMLSchema#string

P932

4924640

http://www.w3.org/2001/XMLSchema#string